[PCRX] QoQ Quarter Result on 30-Sep-2021 [#Q3]

Stock
[PCRX] Pacira BioSciences, Inc.
Announcement Date
03-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- -7.45%
YoY- -86.43%
Quarter Report
PCRX's Result
PCRX's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 169,411 157,991 159,194 127,722 135,590 119,027 128,548 20.26%
PBT 22,007 7,294 -6,197 24,231 25,648 12,724 12,693 44.46%
Tax 2,131 466 -1,068 6,571 6,567 2,355 -1,821 -
NP 19,876 6,828 -5,129 17,660 19,081 10,369 14,514 23.38%
Tax Rate -9.68% -6.39% - -27.12% -25.60% -18.51% 14.35% -
Total Cost 149,535 151,163 164,323 110,062 116,509 108,658 114,034 19.86%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin 11.73 4.32 -3.22 13.83 14.07 8.71 11.29 2.58%
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS 0.40 0.15 -0.12 0.40 0.43 0.24 0.33 13.72%
EPS Diluted 0.38 0.15 -0.12 0.39 0.42 0.23 0.32 12.17%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.